Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
46°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Skechers U.S.A., Inc. Common Stock
(NY:
SKX
)
63.35
+1.53 (+2.47%)
Official Closing Price
Updated: 4:10 PM EST, Feb 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Skechers U.S.A., Inc. Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
MarketBeat: Week in Review 01/09-01/13
January 14, 2023
Markets are looking for direction in early trading before a holiday weekend. Here are some of the popular stories MarketBeat analysts were covering this week.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Skechers to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 2nd
January 12, 2023
From
Skechers USA, Inc.
Via
Business Wire
Skechers Not Nike Is The Sneaker Stock to Own for 2023
January 10, 2023
A tech-driven focus on comfort, omnichannel growth, international expansion and a low P/E are all good reasons to step into Skechers stock.
Via
MarketBeat
Expert Ratings for Skechers USA
December 29, 2022
Via
Benzinga
Analyst Ratings for Skechers USA
December 29, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 29, 2022
December 29, 2022
Via
Benzinga
Skechers' Margins Slated For Strong Expansion In 2023, Says Analyst
December 01, 2022
Via
Benzinga
Where Skechers USA Stands With Analysts
December 01, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
November 16, 2022
Via
Benzinga
Why Skechers Stock Was Down This Morning
October 26, 2022
The stock could be attractive at a low valuation relative to earnings estimates.
Via
The Motley Fool
Insiders Selling Qualcomm, Skechers And 2 Other Stocks
January 05, 2023
The Nasdaq Composite recorded gains on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Skechers USA Stock Showing Market Leadership; Earns 91 RS Rating
January 03, 2023
Skechers USA stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 87 to 91.
Via
Investor's Business Daily
Skechers USA Has Favorable Secular Tailwinds Of Comfort, Says Analyst
December 29, 2022
Via
Benzinga
Inflation and the FTX Collapse Got These Investors Talking
December 24, 2022
And we answer listeners' questions about how many stocks to own, financial aid, and saving for kids.
Via
The Motley Fool
Here's What Wall St Experts Are Saying About Nike Ahead Of Earnings
December 20, 2022
Nike to report Q2 earnings after the market close on Tuesday.
Via
Talk Markets
Nike Earnings Set For Fourth Quarterly Decline, But Key Overhang Lifts For NKE Stock
December 20, 2022
Nike earnings NKE stock
Via
Investor's Business Daily
Time To Buy Nike Stock For 2023?
December 17, 2022
Now is a great time for investors to consider buying NKE for 2023 and beyond. Going over Nike’s fundamentals will help gauge if a rebound is in store.
Via
Talk Markets
Skechers and Ava Max Partner for Global Popstar’s First Footwear Collaboration
November 17, 2022
From
Skechers USA, Inc.
Via
Business Wire
MarketBeat: Week in Review 11/7 – 11/11
November 12, 2022
The midterms, a new CPI report, and a crypto crash are moving the market and the MarketBeat team continues to help you profit from these events
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 Reasons Another Shoe May Drop for Skechers
November 08, 2022
Several hurdles lie ahead as Skechers limps to the finish line in 2022. At some point the stock will be on clearance, but it's nowhere near there right now.
Via
MarketBeat
Skechers Pier to Pier Friendship Walk Breaks New Records With More Than $3 Million Raised for Kids
November 03, 2022
From
Skechers Foundation
Via
Business Wire
Dave Portnoy Says This Is 'Everything That's Wrong With This Country'
October 27, 2022
Dave Portnoy called out people who are still supporting Kanye West on Tuesday, saying that people supporting him along political lines is “everything” that’s wrong with the United States.
Via
Benzinga
Boeing, Seagate, Chipotle And Other Big Losers From Wednesday
October 27, 2022
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping over 200 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Kanye Gets Booted Out Of Skechers LA Office For 'Unauthorized Visit' After Adidas Rebuff
October 26, 2022
Kanye West was escorted out of a Skechers USA, Inc. (NYSE: SKX) office on Wednesday after the footwear company said he arrived "unannounced and without invitation" at one of the company's corporate...
Via
Benzinga
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...
Via
Benzinga
Skechers Issues Statement on Kanye West Unauthorized Visit
October 26, 2022
From
Skechers USA, Inc.
Via
Business Wire
11 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
October 26, 2022
Gainers
Via
Benzinga
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
October 26, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.